Evaluation of the proliferation markers Ki-67/MIB-1, mitosin, survivin, pHH3, and DNA topoisomerase IIα in human anaplastic astrocytomas--an immunohistochemical study - Wikidata - wikimedia - TriplyDB

Evaluation of the proliferation markers Ki-67/MIB-1, mitosin, survivin, pHH3, and DNA topoisomerase IIα in human anaplastic astrocytomas--an immunohistochemical study

Evaluation of the proliferation markers Ki-67/MIB-1, mitosin, survivin, pHH3, and DNA topoisomerase IIα in human anaplastic astrocytomas--an immunohistochemical study

http://www.wikidata.org/entity/Q35081279

about

High frequency of the X-chromosome inactivation in young female patients with high-grade glioma Cerebral blood volume calculated by dynamic susceptibility contrast-enhanced perfusion MR imaging: preliminary correlation study with glioblastoma genetic profiles.Mitotic Index is an Independent Predictor of Recurrence-Free Survival in Meningioma.Ki-67/MIB-1 immunostaining in a cohort of human gliomas.IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II-III diffuse gliomas.Better see to better agree: phosphohistone H3 increases interobserver agreement in mitotic count for meningioma grading and imposes new specific thresholds.pHH3 and survivin are co-expressed in high-risk endometrial cancer and are prognostic relevant Immunohistochemical Expression of Ki-67, PCNA and CD34 in Astrocytomas: A Clinicopathological Study.Histopathological and Immunohistochemical Evaluation of Meningiomas with Reference to Proliferative Markers p53 and Ki-67.P53, MAPK, topoisomerase II alpha and Ki67 immunohistochemical expression and KRAS/BRAF mutation in ovarian serous carcinomas.Expression and clinical significance of the proliferation marker minichromosome maintenance protein 2 (Mcm2) in diffuse astrocytomas WHO grade II Insights into the prognostic value of DJ-1 and MIB-1 in astrocytic tumors.Survivin and gliomas: A literature review Biomarkers classification and therapeutic decision-making for malignant gliomas.Cellular Proliferation Index between Carcinoma Ex-Pleomorphic Adenoma and Pleomorphic Adenoma.Mitosin and pHH3 predict poorer survival in astrocytomas WHO grades II and III.Expression of p53, epidermal growth factor receptor, Ki-67 and O(6)-methylguanine-DNA methyltransferase in human gliomas.Mechanism for G2 phase-specific nuclear export of the kinetochore protein CENP-F.Phosphohistone-H3 Proliferation Index Is Superior to Mitotic Index and MIB-1 Expression as a Predictor of Recurrence in Human Meningiomas.

P2860

Q28387295-1D052BC3-C549-4DAE-8EE9-C0F899AB5537 Q34971940-E125740B-F616-4DF3-A8B9-9D2024D57B31 Q34980413-3834A133-A35E-4C74-912B-361D35ACC981 Q35038363-F606F4E5-6B03-4ACA-9CD8-22F5005C47D3 Q35204658-074B5719-5C2C-473C-8ADF-484B39431645 Q35788622-3CEE6BC1-1BFA-481E-A863-520CD8CF8DC2 Q36075212-DE84B5A0-2229-4616-BC06-CA047C8E5983 Q36321293-66170BA0-F83D-41D6-9D3F-F4D7B9BED703 Q36541821-FB6E3DA1-C045-4C34-A366-76980ACCC6A4 Q36604195-CBB186F5-E688-46A6-A3BC-C3A28373C676 Q36827857-09AC6D8F-6D64-4CDF-A9F9-52CE4359E6ED Q37153458-008BF6A9-007B-4A6F-B284-DFB06D8D753A Q38944673-3740E6B3-E27E-45D0-9A89-D4EDF81CB24B Q39556985-3B18694F-0A68-4478-A7E1-85937DB75AEB Q40601503-1FD190C6-CE0F-4BE7-9C9F-EE9D511B5AAA Q41573611-0A2B0334-271D-4D03-A5E9-FCCE0C1C2DFE Q41893887-2420BF3F-7B9A-4CA2-9F64-F4AC3A2A4F51 Q46575003-BA4F9297-9F99-4744-90F1-33EF10625AAF Q51448302-37B1C6A3-E500-4417-B994-9868FAB8480E

P2860

Evaluation of the proliferation markers Ki-67/MIB-1, mitosin, survivin, pHH3, and DNA topoisomerase IIα in human anaplastic astrocytomas--an immunohistochemical study

http://www.wikidata.org/entity/Q35081279

description

2011 nî lūn-bûn

@nan

2011 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Evaluation of the proliferatio ...... --an immunohistochemical study

@ast

Evaluation of the proliferatio ...... --an immunohistochemical study

@en

type

label

Evaluation of the proliferatio ...... --an immunohistochemical study

@ast

Evaluation of the proliferatio ...... --an immunohistochemical study

@en

prefLabel

Evaluation of the proliferatio ...... --an immunohistochemical study

@ast

Evaluation of the proliferatio ...... --an immunohistochemical study

@en

P1433

Q35081279-D379A150-A7CA-4F24-B7CB-94CE32C3D360

P1476

Q35081279-850A26BC-B173-4B5F-B943-C546FACDAF66

P2093

Q35081279-0D1744CB-04A7-41F8-A4B8-ECDADB443591

Q35081279-1315D4FE-5CA1-477E-84BC-6ABD97BBD4B8

Q35081279-F5006B2D-ACD3-4076-9067-B144D45DE721

P2860

Q35081279-0B2BF784-7EFF-4F9C-B39F-A2E7112E0731

Q35081279-14E2599B-3ACE-48B8-8EA4-76992012DE99

Q35081279-16E29BC7-EC61-492F-B001-18F4E28425B4

Q35081279-180132BF-F282-44AF-8574-59B3E7A075E5

Q35081279-1814E511-B3A6-4E80-9793-4843E1D8FA2B

Q35081279-24E9BE08-BAE1-4361-BC95-AF6959D7EB45

Q35081279-2E3F0D72-AA7D-47D6-A45F-922B3FF925ED

Q35081279-2ECB1F6D-AAB7-4275-BDA4-CB9850717A7D

Q35081279-34769A62-C8EF-4424-884F-438FA115D410

Q35081279-3A784671-1B88-486E-858C-EF6550798130

P2888

Q35081279-68AC6A11-57B0-4785-8471-D2D1E77C38F4

P304

Q35081279-1BAECC45-9796-455D-B766-7D2505C2F744

P31

Q35081279-10A10541-6D41-44AA-B683-3E78596D5D3F

P356

Q35081279-7AABEDDD-EDA9-420D-BC20-F2E0A4EC4B90

P478

Q35081279-0B94A7B5-DCCA-4875-8A14-2EEA49C991F3

P577

Q35081279-15D3CD15-F924-49AF-86A3-47A0A8C4513D

P5875

Q35081279-FF646DBA-FE98-4789-8F37-C8131CED143F

P6179

Q35081279-CBE689BE-2D40-4240-BCDD-AC605BBF93AC

P698

Q35081279-A7D28AD7-A0A3-44D1-B987-510696F0A12F

P932

Q35081279-0E2BFF6E-5CDE-4C6C-8FF9-9F4B8536E2C4

P356

P1433

Diagnostic Pathology

P1476

Evaluation of the proliferatio ...... --an immunohistochemical study

@en

P2093

Andreas H Habberstad

http://www.w3.org/2001/XMLSchema#string

Sasha Gulati

http://www.w3.org/2001/XMLSchema#string

Sverre H Torp

http://www.w3.org/2001/XMLSchema#string

P2860

Control of apoptosis and mitotic spindle checkpoint by survivin

Characterization of a novel 350-kilodalton nuclear phosphoprotein that is specifically involved in mitotic-phase progression

Structure and function of type II DNA topoisomerases

The 2007 WHO classification of tumours of the central nervous system

Nuclear or cytoplasmic expression of survivin: what is the significance?

Mitosis-specific phosphorylation of histone H3 initiates primarily within pericentromeric heterochromatin during G2 and spreads in an ordered fashion coincident with mitotic chromosome condensation

Ki-67 expression is superior to mitotic count and novel proliferation markers PHH3, MCM4 and mitosin as a prognostic factor in thick cutaneous melanoma.

Overexpression of c-erbB2 is a negative prognostic factor in anaplastic astrocytomas.

Cell proliferation and tumors of the central nervous system. Part 1: Evaluation of mitotic activity.

Survivin study: what is the next wave?

P2888

P304

43

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1746-1596-6-43

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2011-05-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51162237

http://www.w3.org/2001/XMLSchema#string

P6179

1007590288

http://www.w3.org/2001/XMLSchema#string

P698

21609421

http://www.w3.org/2001/XMLSchema#string

P932

3127815

http://www.w3.org/2001/XMLSchema#string